tirzepatide and multiple sclerosis You might know them as Ozempic, Wegovy, Mounjaro, Zepbound. GLP-1 receptor agonists are best known for managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective Exploring the association between weight

Over a 52- to 68-week period, clinical trials have shown average weight loss ranging from 11% to 17% of initial body weight

A competent prescriber understands obesity as a disease, the full medication toolkit, the controlled-substance compliance phentermine requires, the side-effect and lean-mass considerations semaglutide brings, and the program-level judgment that decides when to use one, the other, or both in sequence

The Role of a Personalized Program Weight loss is about more than just a shot once a week

Metabolic rate, existing medical conditions, medications you take, and physical activity level all influence the final outcome

Tip: These symptoms usually happen when you first start

Feng P, Sheng X, Ji Y, Urva S, Wang F, Miller S, et al